fda warning glp-1 compounding september 2025 Compounded" drugs | Health Communication Research Laboratory Trends In FDA FY 2025

GLP-1 drugs are changing how people shop for food, clothes, and more, creating a 'seismic shift' in retail.

REDUCE HUNGER & CRAVINGS: Patented and clinically-studied Supresa saffron extract is shown to reduce hunger and snacking in as early as 8 weeks in clinical study participants. SUPPORT WEIGHT MANAGEMENT: Clinically-tested Morosil red orange extract is shown to support fat reduction, reduce BMI and combat visceral fat (in combination with diet and exercise) in clinical study participants. The product is formulated to support healthy weight management

Sensitivity analyses showed that the probability of using GLP-1RAs versus insulin being cost-effective for preventing one case of all-cause mortality or hospitalized hypoglycemia ranged from 60 to 100%

GLP-1 medications like Ozempic, Wegovy, Zepbound, and Mounjaro arent just trending topicstheyre fundamentally reshaping the world of weight loss and client coaching

But for some, the results dont live up to the hype, especially when side effects like bloating or constipation appear

In this blog, well break down how rebates work, why theyve come under increased scrutiny and how transparency especially from your pharmacy benefit manager (PBM) can help your organization truly lower prescription drug costs.